GHK-Cu in Australia: Legal Access, Clinical Use, and Where Cosmetic Serums End

GHK-Cu is a naturally occurring tripeptide — glycyl-L-histidyl-L-lysine — that binds copper(II) with very high affinity. The complex is found in human plasma, where its concentration declines with age. Research interest has focused on wound healing, dermal collagen and elastin synthesis, hair-follicle support, and antioxidant signalling. In Australia patients typically ask about it for two reasons: skin and hair.

The first thing to understand is that there are two completely different categories of GHK-Cu product. The cosmetic copper-peptide serums you can buy at any skincare retailer use low-strength topical GHK-Cu in a cream or serum base, marketed as cosmetics. They don't require a prescription, they're not subject to TGA therapeutic-goods regulation, and they're a different product class entirely. The pharmaceutical-grade injectable GHK-Cu that Australian patients sometimes ask about for medical indications is not on the Australian Register of Therapeutic Goods (ARTG) — and that's the product this article is about.

Injectable GHK-Cu can be lawfully prescribed by an AHPRA-registered Australian doctor under the TGA Special Access Scheme Category B (SAS-B). The doctor lodges a notification with the TGA, documents the clinical justification, and routes the script to a TGA-licensed Australian compounding pharmacy that operates under PIC/S Good Manufacturing Practice. The vial you receive has been compounded individually for you, batch-tested for identity, sterility, and potency.

What it is NOT: an over-the-counter product sold at Chemist Warehouse, Priceline, or any Australian pharmacy as a finished medicine. It's not on the ARTG, so no Australian pharmacy stocks it as a packaged product. And it's not lawful to import yourself from offshore "research peptide" vendors — those vials carry no guarantee of identity, sterility, or potency, and Customs routinely seize peptide shipments under the Customs Act.

Typical clinical contexts where an Australian prescriber will consider it: skin quality and dermal repair, hair density (often alongside other modalities), adjunctive support for chronic slow-healing wounds, and post-procedural skin recovery. It is not a first-line therapy for anything — your doctor will look at what has already been tried, the underlying clinical picture, and whether SAS-B prescribing is justified.

How to access it in 2026: most GPs don't prescribe injectable GHK-Cu because the SAS-B paperwork and compounding logistics are outside routine general practice. The realistic pathway is a peptide-specialist telehealth service — complete an intake, an AHPRA-registered Australian doctor reviews your history, and if appropriate they lodge the SAS-B notification. Expect roughly AUD $160–$300 per month for the compounded vial, plus a $99 initial telehealth consult.

If you're searching for "GHK-Cu legal in Australia" or "where to buy GHK-Cu in Australia", the honest answer is: not over the counter, not online from overseas, not at Chemist Warehouse. The lawful path is AHPRA-registered doctor → TGA SAS-B → TGA-licensed Australian compounding pharmacy → you.